Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ashley Morphey"'
Autor:
Elisabet E. Manasanch, Jatin J. Shah, Hans C. Lee, Donna M. Weber, Sheeba K. Thomas, Behrang Amini, Jasper Olsem, Brandon Crumpton, Ashley Morphey, Zuzana Berkova, Lei Feng, Robert Z. Orlowski
Publikováno v:
Haematologica, Vol 105, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/42818f7edd4b47b2aa9ac5550ba12c44
Autor:
Robert Z. Orlowski, Donna M. Weber, Muzaffar H. Qazilbash, Qaiser Bashir, Sheeba K. Thomas, Xiao Jiao Huo, Ashley Morphey, Jasper Olsem, Elisabet M. Manasanch, Hans C. Lee, Lei Feng, Jatin J. Shah, Krina K. Patel
Supplementary Table from Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ed6cb02ccbc6a13a84d5107d924ef0
https://doi.org/10.1158/1078-0432.22486829.v1
https://doi.org/10.1158/1078-0432.22486829.v1
Autor:
Robert Z. Orlowski, Donna M. Weber, Muzaffar H. Qazilbash, Qaiser Bashir, Sheeba K. Thomas, Xiao Jiao Huo, Ashley Morphey, Jasper Olsem, Elisabet M. Manasanch, Hans C. Lee, Lei Feng, Jatin J. Shah, Krina K. Patel
Supplementary Figure from Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4269a2958a66f83c9ac43cb9e6c54fce
https://doi.org/10.1158/1078-0432.22486832.v1
https://doi.org/10.1158/1078-0432.22486832.v1
Autor:
Robert Z. Orlowski, Donna M. Weber, Muzaffar H. Qazilbash, Qaiser Bashir, Sheeba K. Thomas, Xiao Jiao Huo, Ashley Morphey, Jasper Olsem, Elisabet M. Manasanch, Hans C. Lee, Lei Feng, Jatin J. Shah, Krina K. Patel
Purpose:In this study, the addition of ixazomib to lenalidomide maintenance post-autologous stem cell transplant (ASCT) in 64 patients with newly diagnosed multiple myeloma was evaluated on the basis of the observed benefit of lenalidomide-only maint
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82e6aca06ff2da252e789d6fb49cd52e
https://doi.org/10.1158/1078-0432.c.6532400.v1
https://doi.org/10.1158/1078-0432.c.6532400.v1
Autor:
Krina K. Patel, Jatin J. Shah, Lei Feng, Hans C. Lee, Elisabet M. Manasanch, Jasper Olsem, Ashley Morphey, Xiao Jiao Huo, Sheeba K. Thomas, Qaiser Bashir, Muzaffar H. Qazilbash, Donna M. Weber, Robert Z. Orlowski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 28(7)
Purpose: In this study, the addition of ixazomib to lenalidomide maintenance post-autologous stem cell transplant (ASCT) in 64 patients with newly diagnosed multiple myeloma was evaluated on the basis of the observed benefit of lenalidomide-only main
Autor:
Sheeba K. Thomas, Ashley Morphey, Donna M. Weber, Robert Z. Orlowski, Jatin J. Shah, Brandon N. Crumpton, Zuzana Berkova, Jasper B. Olsem, Behrang Amini, Lei Feng, Hans C. Lee, Elisabet E. Manasanch
Publikováno v:
Haematologica
Autor:
Elisabet E. Manasanch, Donna M. Weber, Muzaffar H. Qazilbash, Robert Z. Orlowski, Krina K. Patel, Hans C. Lee, Qaiser Bashir, Jatin J. Shah, Sheeba K. Thomas, Ashley Morphey, Jasper B. Olsem, Xiao Jiao Huo, Lei Feng
Publikováno v:
Blood. 138:4774-4774
Backrground: Several randomized controlled clinical trials have demonstrated improved outcomes for newly diagnosed multiple myeloma (NDMM) patients who were treated with lenalidomide as maintenance therapy after autologous stem cell transplant (ASCT)
Autor:
Muzaffar H. Qazilbash, Sheeba K. Thomas, Neeraj Saini, Ralph J. Johnson, Donna M. Weber, Gregory P. Kaufman, Jatin J. Shah, Elisabet E. Manasanch, Brandon N. Crumpton, Hans C. Lee, Behrang Amini, Ashley Morphey, Armando Morin, Mildred D. Stafford, Krina K. Patel, Lei Feng, Robert Z. Orlowski, Qaiser Bashir, Swami P. Iyer, Samer A. Srour
Publikováno v:
Blood. 136:46-47
Background: Lenalidomide (LEN) monotherapy has been effective in extending progression free survival (PFS) after AuSCT in pts with MM. Elotuzumab (ELO), a humanized IgG1 immunostimulatory monoclonal antibody against signaling lymphocytic activation m
Autor:
Sheeba K. Thomas, Jatin J. Shah, Donna M. Weber, Ashley Morphey, Hans C. Lee, Robert Z. Orlowski, Michael L. Wang, Emily Wesson, Ralph J. Johnson, Lei Feng, Raymond Alexanian
Publikováno v:
American Journal of Hematology. 94
Autor:
Sheeba K. Thomas, Jatin J. Shah, Elisabet E. Manasanch, Brandon N. Crumpton, Suzanne Phillips, Ralph J. Johnson, Krina K. Patel, Behrang Amini, Robert Z. Orlowski, Lei Feng, Donna M. Weber, Swaminathan P. Iyer, Ashley Morphey, Carla P Miller, Hans C. Lee
Publikováno v:
Blood. 132:1982-1982
Background: Lenalidomide (LEN) monotherapy has been effective in extending progression free survival (PFS) after myeloablative AuSCT in pts with MM. Elotuzumab (ELO), a humanized IgG1 immunostimulatory monoclonal antibody against signaling lymphocyti